AstraZeneca

AstraZeneca plc is an Anglo-Swedish multinational pharmaceutical and biopharmaceutical company with headquarters in Cambridge, England. Its R & D centers are concentrated in Cambridge, Gaithersburg, Maryland, and Molndal, Sweden.

Since 2020, the whole world has suffered severe consequences due to COVID-19. And AstraZeneca's COVID-19 vaccine is more than 89% effective in protecting people against the causative agent of COVID-19, based on clinical studies.

Recent data from Public Health England (PHE) demonstrates that two doses of AstraZeneca's COVID-19 vaccine are 92% effective in reducing hospital admissions due to the Delta variant and show no cases. There were no deaths among those who received the vaccine.

COVID-19 vaccine Astrazeneca is a vaccine used to protect people 18 years of age and older against COVID-19. The vaccine helps the immune system of the vaccinated person to recognize and destroy the coronavirus (SARS-COV-2). This is the virus that causes COVID-19 disease, which causes some patients to become severe and possibly fatal.

Country: UK

Market Cap Value: $152.28 Billion

Website: https://www.astrazeneca.com/

Facebook: https://www.facebook.com/astrazenecacareers